|
 |
How can we help you? |
|
|
| |
|
|
| |
 |
|
|
|
| |
Patni Life Sciences Veteran to Speak at DIA
Annual Meeting |
Patni VP Steve Jolley Joins FDA Leader to co-present on
Pharmacovigilance
and Risk Assessment at June 22 Event
|
BOSTON – June 9, 2008: Patni Computer Systems (NYSE: PTI), a leading global IT services provider, today announced that Steve T. Jolley, Vice-President of Pharmacovigilance at Patni Life Sciences, will co-present with Carol L. Krueger, BSN, RN, with the FDA’s Surveillance Programs Team, at the U.S. Food & Drug Administration, at the Drug Information Association’s 44th Annual Meeting during June 22-25 in Boston.
Jolley and Krueger will present a tutorial on “Pharmacovigilance Assessment and Risk Management: Essential Components to Good Pharmacovigilance Practice”. The session, designed for professionals working in pharmacovigilance and drug safety, clinical research and regulatory affairs, is scheduled to run from 8:30 a.m. to noon at the Boston Convention and Exhibition Center.
Jolley is Patni’s subject matter expert in all areas of pharmacovigilance, with responsibility for developing and delivering solutions surrounding pharmacovigilance-related policies, processes, systems and infrastructure. He has more than 20 years experience in the pharmaceutical arena.
“As pharmaceutical companies face an increasingly complex set of international regulations, demonstrating commitment to Good Pharmacovigilance Practice is essential to drug development and commercialization.” Jolley said. “Those who perform thorough assessments, develop pre- and post-market risk surveillance programs, and keep up with updates to existing government guidances and regulations will position themselves for success in this challenging market.”
Jolley, who is active in pharmaceutical industry forums, participated in a “think tank” meeting on pharmacovigilance and data mining involving 60 select industry leaders last week at the Universities at Shady Grove in Rockville, MD. The workshop, “Best Practices in Pharmacovigilance: Developing Standards for Data Mining,” was organized by the Center for Drugs and Public Policy at the University of Maryland School of Pharmacy. Professionals from academia, industry, government and regulatory agencies were selected based on their expertise and ongoing involvement in data mining.
About Patni
Patni Computer Systems Limited (BSE: PATNI COMPUT, NSE: PATNI, NYSE: PTI) is a global provider of IT Services and business solutions, servicing Global 2000 clients. Patni caters to its clients through its industry-focused practices, including insurance, financial services, manufacturing, life sciences, telecommunications and media & entertainment, and its technology-focused practices.
With an employee strength of over 15,000; multiple global delivery centres spread across 11 cities worldwide; 22 international offices across the Americas, Europe and Asia-Pacific; Patni has registered revenues of US$ 663 million for the year 2007. Patni’s service offerings include application development and maintenance, enterprise application solutions, business and technology consulting, product engineering services, infrastructure management services, customer interaction services & business process outsourcing, quality assurance and engineering services.
Committed to quality, Patni adds value to its client's businesses through well-established and structured methodologies, tools and techniques. Patni is an ISO 9001: 2000 certified and SEI-CMMI Level 5 (V 1.2) organization, assessed enterprise wide at P-CMM Level 3. In keeping with its focus on continuous process improvements, Patni adopts Six Sigma practices as an integral part of its quality and process frameworks.
For more information on Patni, visit www.patni.com
Safe Harbor:
Certain statements in this release concerning our future growth prospects are forward-looking statements, which involve a number of risks, and uncertainties that could cause actual results to differ materially from those in such forward-looking statements. The risks and uncertainties relating to these statements include, but are not limited to, risks and uncertainties regarding fluctuations in earnings, our ability to manage growth, intense competition in IT services including those factors which may affect our cost advantage, wage increases in India, our ability to attract and retain highly skilled professionals, time and cost overruns on fixed-price, fixed-time frame contracts, client concentration, restrictions on immigration, our ability to manage our international operations, reduced demand for technology in our key focus areas, disruptions in telecommunication networks, liability for damages on our service contracts, the success of the companies in which Patni has made strategic investments, withdrawal of governmental fiscal incentives, political instability, legal restrictions on raising capital or acquiring companies outside India, and unauthorized use of our intellectual property and general economic conditions affecting our industry. The company does not undertake to update any forward-looking statement that may be made from time to time by or on behalf of the Company.
|
|
|
|
